Skip to main
ALAB
ALAB logo

ALAB Market Capitalization Overview

Market Cap: $24.49B as of Dec 16, 2025

$24.49B
$101.35M (0.42%)past month
As of Dec 16, 2025, ALAB has a market capitalization of $24.49B. Over the past 30 days, its market cap has decreased by -12.37%, while in the last 12 months, it has increased by 16.53%.

Market capitalization represents the total value of Astera Labs Inc as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

ALAB Market Cap Formula = Stock Price * Shares Outstanding

The market cap of ALAB helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

ALAB Market Cap History

DateMarket CapChange
Dec 1, 2025$27.91B-12.37%
Nov 3, 2025$31.85B-1.51%
Oct 1, 2025$32.33B+11.63%
Sep 2, 2025$28.97B+33.96%
Aug 1, 2025$21.63B+47.87%
Jul 1, 2025$14.63B-4.58%
Jun 2, 2025$15.33B+34.24%
May 1, 2025$11.42B+13.53%
Apr 1, 2025$10.06B-8.38%
Mar 3, 2025$10.98B-29.48%
Feb 3, 2025$15.57B-27.12%
Jan 2, 2025$21.36B+30.22%

ALAB End of Year Market Cap History

DateMarket CapChange
2025$24.49B+16.53%
2024$21.01B

FAQs About Astera Labs Inc (ALAB) Market Cap

As of Dec 16, 2025, the market capitalization of ALAB is $24.49B. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Astera Labs Inc’s market capitalization has increased by 0.4200%, changing from $24.38B to $24.49B as of Dec 16, 2025.

In the last 3 months, Astera Labs Inc’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Astera Labs Inc’s market capitalization increased from – in January to $21.01B in December, reflecting a — change.

Astera Labs Inc (ALAB)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.